SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN ISSUER
Pursuant to Rule 13a-16 or 15d-16 of the
Securities Exchange Act of 1934
January 28, 2014
KONINKLIJKE PHILIPS N.V.
(Exact name of registrant as specified in its charter)
Royal Philips
(Translation of registrants name into English)
The Netherlands
(Jurisdiction of incorporation or organization)
Breitner Center, Amstelplein 2, 1096 BC Amsterdam, The Netherlands
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F x Form 40-F ¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule101(b)(1): ¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule101(b)(7): ¨
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes ¨ No x
Name and address of person authorized to receive notices
and communications from the Securities and Exchange Commission:
E.P. Coutinho
Koninklijke Philips N.V.
Amstelplein 2
1096 BC Amsterdam The Netherlands
This report comprises a copy of the following press releases:
- Philips Fourth Quarter and Annual Results 2013, dated January 28, 2014.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf, by the undersigned, thereunto duly authorized at Amsterdam, on the 28th day of January 2014.
KONINKLIJKE PHILIPS N.V.
/s/ E.P. Coutinho
(General Secretary)
Q4 2013 Quarterly report
Philips reports fourth-quarter comparable sales growth of 7%; operational results up by 20%; 2013 financial targets achieved
Fourth-quarter highlights
| Comparable sales in growth geographies up 15% |
| EBITA amounted to EUR 884 million, or 13.0% of sales, compared to a loss of EUR 50 million in Q4 2012 |
| EBITA excluding restructuring and other charges increased to EUR 915 million, or 13.5% of sales, compared to EUR 765 million, or 11.3% of sales, in Q4 2012 |
| Net income amounted to EUR 412 million |
| Free cash flow of EUR 608 million |
Full-year highlights
| Full-year comparable sales increased 3% to EUR 23.3 billion |
| Full-year EBITA increased to EUR 2.5 billion, or 10.5% of sales, compared to EUR 1.1 billion, or 4.7% of sales, in 2012 |
| Return on invested capital was 15.3% for the year |
| Proposal to increase dividend to EUR 0.80 per share |
Frans van Houten, CEO:
The fourth quarter of 2013 was another good quarter for Philips, despite the challenging economic environment and ongoing currency headwinds. In the quarter, Lighting and Consumer Lifestyle both delivered strong comparable sales growth of 8%. At Healthcare, comparable sales increased by 4%, while order intake declined 1% as a result of weak markets in the US and Europe. The operational profitability of all sectors improved substantially, driven by good sales growth, gross margin expansion of 2 percentage points and productivity gains, all coming from the Accelerate! program.
We achieved the mid-term financial targets we had set in 2011, thanks to the hard work of our employees. We delivered a compound annual growth rate for comparable sales over the period 20122013 of 4.5%, compared to our target of 4-6%, and did so in a lower GDP growth environment than originally anticipated. Our reported EBITA as a percentage of sales was 10.5%, within our target range of 10-12%, which we achieved despite currency headwinds and changed pension accounting. We also significantly improved our return on invested capital to 15.3%, above the target range of 12-14%.
We are making excellent progress on our Accelerate! journey. We continue to invest in growth opportunities and the Philips brand. Our overhead cost reduction program has resulted in EUR 1 billion of total gross savings to date. We reduced our inventory as a percentage of sales by 260 basis points from 2011 to 2013. Through our Design for Excellence (DfX) program we remain focused on improving gross margins. These ongoing initiatives, as well as the launch of our new brand campaign and our focus on innovation, continue to make Philips a better and more competitive company.
We introduced the EPIQ Ultrasound system, the Vereos digital PET/CT system and the IQon Spectral CT system, which we expect will have a positive effect on future orders for our health care business. Building on our consumer portfolio of locally relevant innovations, we experienced strong growth in China as well as in Europe, driven by higher demand for our home appliances, such as the Air Purifier and Airfryer. As the leading professional lighting solutions and services provider, Philips won a 10-year contract to deliver and service an integrated digital lighting system with 13,000 connected LED fixtures and adaptive energy management controls for parking garages in Washington, DC. We also won a major order to renovate most of Buenos Aires 125,000 street lights with the CityTouch connected LED system. Our new innovations received a record 100-plus design awards in 2013.
Achieving the 2013 financial targets was an important milestone and we have now set our sights on reaching our 2016 targets. We are confident in our ability to further improve our performance by continuing the strong focus on our Accelerate! transformation program. Looking at 2014, we remain cautious because of ongoing macro-economic uncertainties, currency headwinds and softer order intake in Q4 2013. Therefore, we expect that 2014 will be a modest step towards our 2016 targets, also taking into account restructuring to drive the new productivity targets and investments in additional growth initiatives.
Q4 financials: comparable sales and operational results improve across all sectors
Healthcare comparable sales grew by 4% year-on-year. Customer Services recorded high-single-digit growth, while Home Healthcare Solutions achieved mid-single-digit growth. Imaging Systems and Patient Care & Clinical Informatics recorded low-single-digit growth. In growth geographies, comparable sales showed double-digit growth year-on-year, with strong increases in China, Central & Eastern Europe, Latin America and Middle East & Turkey. Currency-comparable equipment order intake declined by 1% year-on-year, with Patient Care & Clinical Informatics achieving low-single-digit growth, while Imaging Systems recorded a low-single-digit decline. EBITA margin excluding restructuring and acquisition-related charges increased by 100 basis points year-on-year to 19.0%.
Consumer Lifestyle comparable sales increased by 8%, with double-digit growth at Domestic Appliances and high-single-digit growth at Health & Wellness, while Personal Care recorded mid-single-digit growth. In the growth geographies, comparable sales showed a strong double-digit increase, while mature geographies achieved low-single-digit growth. EBITA margin excluding restructuring and acquisition-related charges increased to 13.4%, a year-on-year improvement of 2.1 percentage points.
Lighting comparable sales increased by 8%, led by double-digit growth at Lumileds and Automotive. Light Sources & Electronics and Professional Lighting Solutions achieved mid-single-digit growth, while Consumer Luminaires recorded a low-single-digit decline. LED-based sales grew by 48% and now represent 34% of total Lighting sales. In growth geographies, comparable sales showed a double-digit increase. EBITA margin excluding restructuring and acquisition-related charges and other losses was 10.4%, a year-on-year improvement of 2.5 percentage points.
Philips has completed 7% of the EUR 1.5 billion share buy-back program since the start of the program in October 2013.
Please refer to page 21 of this press release for more information about forward-looking statements, third-party market share data, use of non-GAAP information and use of fair-value measurements.
Philips Group
Q4 2013 Quarterly report 3
4 Q4 2013 Quarterly report
Q4 2013 Quarterly report 5
6 Q4 2013 Quarterly report
Q4 2013 Quarterly report 7
8 Q4 2013 Quarterly report
Q4 2013 Quarterly report 9
10 Q4 2013 Quarterly report
Q4 2013 Quarterly report 11
12 Q4 2013 Quarterly report
Q4 2013 Quarterly report 13
Lighting
14 Q4 2013 Quarterly report
Q4 2013 Quarterly report 15
Innovation, Group & Services
16 Q4 2013 Quarterly report |
Q4 2013 Quarterly report 17
Additional information on Audio, Video,
Multimedia and Accessories business
18 Q4 2013 Quarterly report
Full-year highlights
Q4 2013 Quarterly report 19
20 Q4 2013 Quarterly report
Forward-looking statements
Q4 2013 Quarterly report 21
Proposed distribution
22 Q4 2013 Quarterly report
Other information
Q4 2013 Quarterly report 23
Philips quarterly statistics
all amounts in millions of euros unless otherwise stated
2012 | 2013 | |||||||||||||||||||||||||||||||
1st quarter | 2nd quarter | 3rd quarter | 4th quarter | 1st quarter | 2nd quarter | 3rd quarter | 4th quarter | |||||||||||||||||||||||||
Sales |
5,307 | 5,570 | 5,821 | 6,759 | 5,258 | 5,654 | 5,618 | 6,799 | ||||||||||||||||||||||||
comparable sales growth % |
5 | 6 | 7 | 5 | 1 | 3 | 3 | 7 | ||||||||||||||||||||||||
Gross margin |
2,008 | 2,139 | 2,253 | 2,591 | 2,101 | 2,347 | 2,357 | 2,883 | ||||||||||||||||||||||||
as a % of sales |
37.8 | 38.4 | 38.7 | 38.3 | 40.0 | 41.5 | 42.0 | 42.4 | ||||||||||||||||||||||||
Selling expenses |
(1,196 | ) | (1,314 | ) | (1,298 | ) | (1,526 | ) | (1,190 | ) | (1,245 | ) | (1,214 | ) | (1,426 | ) | ||||||||||||||||
as a % of sales |
(22.5 | ) | (23.6 | ) | (22.3 | ) | (22.6 | ) | (22.6 | ) | (22.0 | ) | (21.6 | ) | (21.0 | ) | ||||||||||||||||
G&A expenses |
(199 | ) | (151 | ) | (222 | ) | (273 | ) | (200 | ) | (230 | ) | (253 | ) | (266 | ) | ||||||||||||||||
as a % of sales |
(3.7 | ) | (2.7 | ) | (3.8 | ) | (4.0 | ) | (3.8 | ) | (4.1 | ) | (4.5 | ) | (3.9 | ) | ||||||||||||||||
R&D expenses |
(450 | ) | (440 | ) | (447 | ) | (494 | ) | (424 | ) | (416 | ) | (437 | ) | (456 | ) | ||||||||||||||||
as a % of sales |
(8.5 | ) | (7.9 | ) | (7.7 | ) | (7.3 | ) | (8.1 | ) | (7.4 | ) | (7.8 | ) | (6.7 | ) | ||||||||||||||||
EBIT |
341 | 229 | 254 | (176 | ) | 305 | 509 | 464 | 713 | |||||||||||||||||||||||
as a % of sales |
6.4 | 4.1 | 4.4 | (2.6 | ) | 5.8 | 9.0 | 8.3 | 10.5 | |||||||||||||||||||||||
EBITA |
451 | 339 | 366 | (50 | ) | 402 | 603 | 562 | 884 | |||||||||||||||||||||||
as a % of sales |
8.5 | 6.1 | 6.3 | (0.7 | ) | 7.6 | 10.7 | 10.0 | 13.0 | |||||||||||||||||||||||
Net income (loss) |
183 | 102 | 105 | (420 | ) | 162 | 317 | 281 | 412 | |||||||||||||||||||||||
Net income (loss) attributable to shareholders |
182 | 102 | 104 | (423 | ) | 161 | 317 | 282 | 409 | |||||||||||||||||||||||
Net income (loss) - shareholders per common share in euros - diluted |
0.20 | 0.11 | 0.11 | (0.46 | ) | 0.17 | 0.35 | 0.31 | 0.44 |
24 Q4 2013 Quarterly report
Philips quarterly statistics (continued)
all amounts in millions of euros unless otherwise stated
2012 | 2013 | |||||||||||||||||||||||||||||||
January- March |
January- June |
January- September |
January- December |
January- March |
January- June |
January- September |
January- December |
|||||||||||||||||||||||||
Sales |
5,307 | 10,877 | 16,698 | 23,457 | 5,258 | 10,912 | 16,530 | 23,329 | ||||||||||||||||||||||||
comparable sales growth % |
5 | 6 | 6 | 6 | 1 | 2 | 2 | 3 | ||||||||||||||||||||||||
Gross margin |
2,008 | 4,147 | 6,400 | 8,991 | 2,101 | 4,448 | 6,805 | 9,688 | ||||||||||||||||||||||||
as a % of sales |
37.8 | 38.1 | 38.3 | 38.3 | 40.0 | 40.8 | 41.2 | 41.5 | ||||||||||||||||||||||||
Selling expenses |
(1,196 | ) | (2,510 | ) | (3,808 | ) | (5,334 | ) | (1,190 | ) | (2,435 | ) | (3,649 | ) | (5,075 | ) | ||||||||||||||||
as a % of sales |
(22.5 | ) | (23.1 | ) | (22.8 | ) | (22.7 | ) | (22.6 | ) | (22.3 | ) | (22.1 | ) | (21.8 | ) | ||||||||||||||||
G&A expenses |
(199 | ) | (350 | ) | (572 | ) | (845 | ) | (200 | ) | (430 | ) | (683 | ) | (949 | ) | ||||||||||||||||
as a % of sales |
(3.7 | ) | (3.2 | ) | (3.4 | ) | (3.6 | ) | (3.8 | ) | (3.9 | ) | (4.1 | ) | (4.1 | ) | ||||||||||||||||
R&D expenses |
(450 | ) | (890 | ) | (1,337 | ) | (1,831 | ) | (424 | ) | (840 | ) | (1,277 | ) | (1,733 | ) | ||||||||||||||||
as a % sales |
(8.5 | ) | (8.2 | ) | (8.0 | ) | (7.8 | ) | (8.1 | ) | (7.7 | ) | (7.7 | ) | (7.4 | ) | ||||||||||||||||
EBIT |
341 | 570 | 824 | 648 | 305 | 814 | 1,278 | 1,991 | ||||||||||||||||||||||||
as a % of sales |
6.4 | 5.2 | 4.9 | 2.8 | 5.8 | 7.5 | 7.7 | 8.5 | ||||||||||||||||||||||||
EBITA |
451 | 790 | 1,156 | 1,106 | 402 | 1,005 | 1,567 | 2,451 | ||||||||||||||||||||||||
as a % of sales |
8.5 | 7.3 | 6.9 | 4.7 | 7.6 | 9.2 | 9.5 | 10.5 | ||||||||||||||||||||||||
Net income (loss) |
183 | 285 | 390 | (30 | ) | 162 | 479 | 760 | 1,172 | |||||||||||||||||||||||
Net income (loss) attributable to shareholders |
182 | 284 | 388 | (35 | ) | 161 | 478 | 760 | 1,169 | |||||||||||||||||||||||
Net income (loss) - shareholders per common share in euros - diluted |
0.20 | 0.31 | 0.42 | (0.04 | ) | 0.17 | 0.52 | 0.83 | 1.27 | |||||||||||||||||||||||
Net income (loss) from continuing operations as a % of shareholders equity |
6.3 | 4.3 | 4.0 | (0.6 | ) | 5.8 | 9.0 | 9.4 | 10.6 | |||||||||||||||||||||||
period ended 2012 | period ended 2013 | |||||||||||||||||||||||||||||||
Number of common shares outstanding (after deduction of treasury shares) at the end of period (in thousands) |
915,926 | 931,391 | 923,912 | 914,591 | 905,381 | 913,874 | 915,095 | 913,338 | ||||||||||||||||||||||||
Shareholders equity per common share in euros |
13.35 | 13.01 | 13.01 | 12.19 | 12.33 | 11.78 | 11.93 | 12.28 | ||||||||||||||||||||||||
Inventories as a % of sales1) |
16.9 | 17.2 | 16.9 | 14.3 | 15.5 | 15.7 | 16.5 | 13.9 | ||||||||||||||||||||||||
Inventories excluding discontinued operations |
3,623 | 3,812 | 3,877 | 3,359 | 3,629 | 3,696 | 3,832 | 3,239 | ||||||||||||||||||||||||
Net debt : group equity ratio |
6:94 | 13:87 | 11:89 | 6:94 | 12:88 | 16:84 | 16:84 | 11:89 | ||||||||||||||||||||||||
Net operating capital |
10,634 | 11,485 | 11,048 | 9,316 | 9,969 | 10,184 | 10,249 | 10,238 | ||||||||||||||||||||||||
Total employees |
122,008 | 121,801 | 121,284 | 118,087 | 117,881 | 117,239 | 116,266 | 116,681 | ||||||||||||||||||||||||
of which discontinued operations |
2,285 | 2,166 | 2,058 | 2,005 | 1,970 | 1,958 | 1,940 | 1,992 |
1) | sales is calculated over the preceding 12 months |
Q4 2013 Quarterly report 25
Condensed consolidated statements of income
in millions of euros unless otherwise stated
4th quarter | January to December | |||||||||||||||
2012 | 2013 | 2012 | 2013 | |||||||||||||
Sales |
6,759 | 6,799 | 23,457 | 23,329 | ||||||||||||
Cost of sales |
(4,168 | ) | (3,916 | ) | (14,466 | ) | (13,641 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Gross margin |
2,591 | 2,883 | 8,991 | 9,688 | ||||||||||||
Selling expenses |
(1,526 | ) | (1,426 | ) | (5,334 | ) | (5,075 | ) | ||||||||
General and administrative expenses |
(273 | ) | (266 | ) | (845 | ) | (949 | ) | ||||||||
Research and development expenses |
(494 | ) | (456 | ) | (1,831 | ) | (1,733 | ) | ||||||||
Impairment of goodwill |
0 | (28 | ) | 0 | (28 | ) | ||||||||||
Other business income |
34 | 21 | 275 | 123 | ||||||||||||
Other business expenses |
(508 | ) | (15 | ) | (608 | ) | (35 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Income from operations |
(176 | ) | 713 | 648 | 1,991 | |||||||||||
Financial income |
44 | 19 | 106 | 70 | ||||||||||||
Financial expenses |
(83 | ) | (96 | ) | (435 | ) | (400 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Income before taxes |
(215 | ) | 636 | 319 | 1,661 | |||||||||||
Income tax expense |
(27 | ) | (168 | ) | (185 | ) | (466 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Income after taxes |
(242 | ) | 468 | 134 | 1,195 | |||||||||||
Results relating to investments in associates |
(193 | ) | (46 | ) | (211 | ) | (25 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net income from continuing operations |
(435 | ) | 422 | (77 | ) | 1,170 | ||||||||||
Discontinued operations - net of income tax |
15 | (10 | ) | 47 | 2 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net income |
(420 | ) | 412 | (30 | ) | 1,172 | ||||||||||
Attribution of net income for the period |
||||||||||||||||
Net income attributable to shareholders |
(423 | ) | 409 | (35 | ) | 1,169 | ||||||||||
Net income attributable to non-controlling interests |
3 | 3 | 5 | 3 | ||||||||||||
Earnings per common share attributable to shareholders |
||||||||||||||||
Weighted average number of common shares outstanding (after deduction of treasury shares) during the period (in thousands): |
||||||||||||||||
- basic |
918,223 | 1) | 914,385 | 922,101 | 1) | 911,072 | ||||||||||
- diluted |
927,486 | 1) | 927,131 | 927,222 | 1) | 922,072 | ||||||||||
Net income attributable to shareholders per common share in euros: |
||||||||||||||||
- basic |
(0.46 | ) | 0.45 | (0.04 | ) | 1.28 | ||||||||||
- diluted |
(0.46 | )2) | 0.44 | (0.04 | )2) | 1.27 |
1) | Adjusted to make 2012 comparable for the elective share dividend premium (273 thousand) issued in June 2013 |
2) | The incremental shares from assumed conversion are not taken into account in the periods for which there is a loss attributable to shareholders, as the effect would be antidilutive |
26 Q4 2013 Quarterly report
Condensed consolidated balance sheets
in millions of euros unless otherwise stated
December 31, | December 31, | |||||||
2012 | 2013 | |||||||
Non-current assets: |
||||||||
Property, plant and equipment |
2,959 | 2,780 | ||||||
Goodwill |
6,948 | 6,504 | ||||||
Intangible assets excluding goodwill |
3,731 | 3,262 | ||||||
Non-current receivables |
176 | 144 | ||||||
Investments in associates |
177 | 161 | ||||||
Other non-current financial assets |
549 | 496 | ||||||
Deferred tax assets |
1,919 | 1,675 | ||||||
Other non-current assets |
94 | 63 | ||||||
|
|
|
|
|||||
Total non-current assets |
16,553 | 15,085 | ||||||
Current assets: |
||||||||
Inventories - net |
3,495 | 3,240 | ||||||
Other current financial assets |
| 10 | ||||||
Other current assets |
337 | 354 | ||||||
Derivative financial assets |
137 | 150 | ||||||
Income tax receivable |
97 | 70 | ||||||
Receivables |
4,585 | 4,678 | ||||||
Assets classified as held for sale |
43 | 507 | ||||||
Cash and cash equivalents |
3,834 | 2,465 | ||||||
|
|
|
|
|||||
Total current assets |
12,528 | 11,474 | ||||||
|
|
|
|
|||||
Total assets |
29,081 | 26,559 | ||||||
Shareholders equity |
11,151 | 11,214 | ||||||
Non-controlling interests |
34 | 13 | ||||||
|
|
|
|
|||||
Group equity |
11,185 | 11,227 | ||||||
Non-current liabilities: |
||||||||
Long-term debt |
3,725 | 3,309 | ||||||
Long-term provisions |
2,119 | 1,903 | ||||||
Deferred tax liabilities |
92 | 76 | ||||||
Other non-current liabilities |
2,005 | 1,568 | ||||||
|
|
|
|
|||||
Total non-current liabilities |
7,941 | 6,856 | ||||||
Current liabilities: |
||||||||
Short-term debt |
809 | 592 | ||||||
Derivative financial liabilities |
517 | 368 | ||||||
Income tax payable |
200 | 143 | ||||||
Accounts and notes payable |
2,839 | 2,462 | ||||||
Accrued liabilities |
3,171 | 2,830 | ||||||
Short-term provisions |
837 | 651 | ||||||
Liabilities directly associated with assets held for sale |
27 | 348 | ||||||
Other current liabilities |
1,555 | 1,082 | ||||||
|
|
|
|
|||||
Total current liabilities |
9,955 | 8,476 | ||||||
|
|
|
|
|||||
Total liabilities and group equity |
29,081 | 26,559 |
Q4 2013 Quarterly report 27
Condensed consolidated statements of cash flows
in millions of euros
4th quarter | January to December | |||||||||||||||
2012 | 2013 | 2012 | 2013 | |||||||||||||
Cash flows from operating activities: |
||||||||||||||||
Net income |
(420 | ) | 412 | (30 | ) | 1,172 | ||||||||||
Result of discontinued operations - net of income tax |
(15 | ) | 10 | (47 | ) | (2 | ) | |||||||||
Adjustments to reconcile net income to net cash provided by operating activities: |
||||||||||||||||
Fixed assets depreciation, amortization, and impairments |
382 | 403 | 1,398 | 1,349 | ||||||||||||
Impairment of goodwill and other non-current financial assets |
2 | 32 | 14 | 38 | ||||||||||||
Net loss (gain) on sale of assets |
18 | (5 | ) | (141 | ) | (54 | ) | |||||||||
(Income) loss from investments in associates |
(4 | ) | 47 | 5 | 25 | |||||||||||
Dividends received from investments in associates |
8 | | 15 | 6 | ||||||||||||
Dividends paid to non-controlling interests |
(4 | ) | (7 | ) | (4 | ) | (7 | ) | ||||||||
Decrease (increase) in working capital: |
780 | (170 | ) | 546 | (1,417 | ) | ||||||||||
Increase in receivables and other current assets |
(82 | ) | (109 | ) | (191 | ) | (530 | ) | ||||||||
Decrease (increase) in inventories |
411 | 497 | (32 | ) | (165 | ) | ||||||||||
Increase (decrease) in accounts payable, accrued and other liabilities |
451 | (558 | ) | 769 | (722 | ) | ||||||||||
(Increase) decrease in non-current receivables, other assets and other liabilities |
(136 | ) | 3 | (327 | ) | (76 | ) | |||||||||
Increase (decrease) in provisions |
322 | 49 | 429 | (194 | ) | |||||||||||
Other items |
123 | 131 | 224 | 298 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net cash provided by operating activities |
1,056 | 905 | 2,082 | 1,138 | ||||||||||||
Cash flows from investing activities: |
||||||||||||||||
Purchase of intangible assets |
(9 | ) | (32 | ) | (34 | ) | (49 | ) | ||||||||
Proceeds from sale of intangible assets |
| | 160 | | ||||||||||||
Expenditures on development assets |
(95 | ) | (89 | ) | (345 | ) | (357 | ) | ||||||||
Capital expenditures on property, plant and equipment |
(212 | ) | (181 | ) | (661 | ) | (587 | ) | ||||||||
Proceeds from disposals of property, plant and equipment |
13 | 5 | 425 | 27 | ||||||||||||
Cash from (to) derivatives and current financial assets |
8 | (8 | ) | (46 | ) | (101 | ) | |||||||||
Purchase of other non-current financial assets |
(4 | ) | (8 | ) | (167 | ) | (13 | ) | ||||||||
Proceeds from other non-current financial assets |
3 | | 3 | 15 | ||||||||||||
Purchase of businesses, net of cash acquired |
(8 | ) | (6 | ) | (261 | ) | (11 | ) | ||||||||
Proceeds from sale of interests in businesses, net of cash disposed of |
(12 | ) | (6 | ) | 1 | 79 | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net cash used for investing activities |
(316 | ) | (325 | ) | (925 | ) | (997 | ) | ||||||||
Cash flows from financing activities: |
||||||||||||||||
Proceeds from (payments on) issuance of short-term debt |
(35 | ) | (82 | ) | 133 | (285 | ) | |||||||||
Principal payments on long-term debt |
(42 | ) | (19 | ) | (631 | ) | (186 | ) | ||||||||
Proceeds from issuance of long-term debt |
27 | 16 | 1,228 | 64 | ||||||||||||
Treasury shares transactions |
(191 | ) | (57 | ) | (768 | ) | (562 | ) | ||||||||
Dividends paid |
| | (255 | ) | (272 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net cash used for financing activities |
(241 | ) | (142 | ) | (293 | ) | (1,241 | ) | ||||||||
Net cash provided by (used for) continuing operations |
499 | 438 | 864 | (1,100 | ) | |||||||||||
Cash flows from discontinued operations: |
||||||||||||||||
Net cash provided by (used for) operating activities |
107 | 17 | (166 | ) | (159 | ) | ||||||||||
Net cash provided by (used for) investing activities |
(33 | ) | 3 | 40 | (47 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net cash provided by (used for) discontinued operations |
74 | 20 | (126 | ) | (206 | ) | ||||||||||
Net cash provided by (used for) continuing and discontinued operations |
573 | 458 | 738 | (1,306 | ) |
28 Q4 2013 Quarterly report
4th quarter | January to December | |||||||||||||||
Effect of change in exchange rates on cash and cash equivalents |
29 | (27 | ) | (51 | ) | (63 | ) | |||||||||
Cash and cash equivalents at the beginning of the period |
3,232 | 2,034 | 3,147 | 3,834 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Cash and cash equivalents at the end of the period |
3,834 | 2,465 | 3,834 | 2,465 | ||||||||||||
Net cash paid during the period for |
||||||||||||||||
Pensions |
(120 | ) | (190 | ) | (610 | ) | (679 | ) | ||||||||
Interest |
(29 | ) | (13 | ) | (239 | ) | (215 | ) | ||||||||
Income taxes |
(84 | ) | (76 | ) | (359 | ) | (454 | ) |
For a number of reasons, principally the effects of translation differences, certain items in the statements of cash flows do not correspond to the differences between the balance sheet amounts for the respective items.
Q4 2013 Quarterly report 29
Condensed consolidated statement of changes in equity
in millions of euros
common shares |
capital in excess of par value |
retained earnings |
revaluation reserve |
currency translation differences |
available- for-sale financial assets |
cash flow hedges |
treasury shares at cost |
total shareholders equity |
non-controlling interests |
total equity |
||||||||||||||||||||||||||||||||||
January-December 2013 |
||||||||||||||||||||||||||||||||||||||||||||
Balance as of December 31, 2012 |
191 | 1,304 | 10,724 | 54 | (93 | ) | 54 | 20 | (1,103 | ) | 11,151 | 34 | 11,185 | |||||||||||||||||||||||||||||||
Net income |
1,169 | 1,169 | 3 | 1,172 | ||||||||||||||||||||||||||||||||||||||||
Other comprehensive income, net of tax |
93 | (31 | ) | (476 | ) | 1 | 4 | (409 | ) | (409 | ) | |||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Total comprehensive income |
1,262 | (31 | ) | (476 | ) | 1 | 4 | 760 | 3 | 763 | ||||||||||||||||||||||||||||||||||
Dividend distributed |
4 | 402 | (678 | ) | (272 | ) | (272 | ) | ||||||||||||||||||||||||||||||||||||
Movement non-controlling interest |
| | (24 | ) | (24 | ) | ||||||||||||||||||||||||||||||||||||||
Cancellation of treasury shares |
(7 | ) | (780 | ) | 787 | | | |||||||||||||||||||||||||||||||||||||
Purchase of treasury shares |
(38 | ) | (631 | ) | (669 | ) | (669 | ) | ||||||||||||||||||||||||||||||||||||
Re-issuance of treasury shares |
(36 | ) | (75 | ) | 229 | 118 | 118 | |||||||||||||||||||||||||||||||||||||
Share-based compensation plans |
105 | 105 | 105 | |||||||||||||||||||||||||||||||||||||||||
Income tax share-based |
21 | 21 | 21 | |||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Total other equity movements |
(3 | ) | 492 | (1,571 | ) | | | | | 385 | (697 | ) | (24 | ) | (721 | ) | ||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Balance as of December 31, 2013 |
188 | 1,796 | 10,415 | 23 | (569 | ) | 55 | 24 | (718 | ) | 11,214 | 13 | 11,227 |
30 Q4 2013 Quarterly report
Sectors
in millions of euros unless otherwise stated
Sales and income from operations
4th quarter | ||||||||||||||||||||||||
2012 |
2013 |
|||||||||||||||||||||||
sales | income from operations | sales | income from operations | |||||||||||||||||||||
as a % of sales | as a % of sales | |||||||||||||||||||||||
Healthcare |
2,918 | 361 | 12.4 | 2,828 | 477 | 16.9 | ||||||||||||||||||
Consumer Lifestyle |
1,385 | 113 | 8.2 | 1,428 | 174 | 12.2 | ||||||||||||||||||
Lighting |
2,262 | (88 | ) | (3.9 | ) | 2,306 | 124 | 5.4 | ||||||||||||||||
Innovation, Group & Services |
194 | (562 | ) | | 237 | (62 | ) | | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Philips Group |
6,759 | (176 | ) | (2.6 | ) | 6,799 | 713 | 10.5 | ||||||||||||||||
Sales and income from operations
|
||||||||||||||||||||||||
January to December | ||||||||||||||||||||||||
2012 |
2013 |
|||||||||||||||||||||||
sales | income from operations | sales | income from operations | |||||||||||||||||||||
as a % of sales | as a % of sales | |||||||||||||||||||||||
Healthcare |
9,983 | 1,026 | 10.3 | 9,575 | 1,315 | 13.7 | ||||||||||||||||||
Consumer Lifestyle |
4,319 | 400 | 9.3 | 4,605 | 429 | 9.3 | ||||||||||||||||||
Lighting |
8,442 | (66 | ) | (0.8 | ) | 8,413 | 489 | 5.8 | ||||||||||||||||
Innovation, Group & Services |
713 | (712 | ) | | 736 | (242 | ) | | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Philips Group |
23,457 | 648 | 2.8 | 23,329 | 1,991 | 8.5 |
Q4 2013 Quarterly report 31
Sectors and main countries
in millions of euros
Sales, total assets and total liabilities
sales |
total assets |
total liabilities excluding debt |
||||||||||||||||||||||
January to December |
December 31, | December 31, | December 31, | December 31, | ||||||||||||||||||||
2012 | 2013 | 2012 | 2013 | 2012 | 2013 | |||||||||||||||||||
Healthcare |
9,983 | 9,575 | 11,248 | 10,465 | 3,186 | 2,943 | ||||||||||||||||||
Consumer Lifestyle |
4,319 | 4,605 | 3,280 | 2,832 | 2,075 | 1,571 | ||||||||||||||||||
Lighting |
8,442 | 8,413 | 6,970 | 6,711 | 2,313 | 2,229 | ||||||||||||||||||
Innovation, Group & Services |
713 | 736 | 7,540 | 6,044 | 5,761 | 4,340 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||
29,038 | 26,052 | 13,335 | 11,083 | |||||||||||||||||||||
Assets and liabilities classified as held for sale |
43 | 507 | 27 | 348 | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Philips Group |
23,457 | 23,329 | 29,081 | 26,559 | 13,362 | 11,431 |
Sales and tangible and intangible assets
sales |
tangible and intangible assets1) | |||||||||||||||
January to December |
December 31, | December 31, | ||||||||||||||
2012 | 2013 | 2012 | 2013 | |||||||||||||
Netherlands |
627 | 656 | 886 | 915 | ||||||||||||
United States |
6,824 | 6,442 | 8,007 | 7,384 | ||||||||||||
China |
2,585 | 2,942 | 1,114 | 1,057 | ||||||||||||
Germany |
1,323 | 1,355 | 271 | 288 | ||||||||||||
Japan |
1,204 | 1,006 | 537 | 401 | ||||||||||||
France |
941 | 915 | 90 | 80 | ||||||||||||
United Kingdom |
676 | 692 | 628 | 573 | ||||||||||||
Other countries |
9,277 | 9,321 | 2,105 | 1,848 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Philips Group |
23,457 | 23,329 | 13,638 | 12,546 |
1) | Includes property, plant and equipment, goodwill, and intangible assets excluding goodwill |
32 Q4 2013 Quarterly report
Pension costs
in millions of euros
Specification of pension costs
4th quarter | ||||||||||||||||||||||||
2012 |
2013 |
|||||||||||||||||||||||
Netherlands | other | total | Netherlands | other | total | |||||||||||||||||||
Defined-benefit plans |
||||||||||||||||||||||||
Pensions |
||||||||||||||||||||||||
Current service cost |
43 | 21 | 64 | 48 | 18 | 66 | ||||||||||||||||||
Past service cost (incl. curtailments) |
(25 | ) | (6 | ) | (31 | ) | | (3 | ) | (3 | ) | |||||||||||||
Settlements |
| 1 | 1 | | 1 | 1 | ||||||||||||||||||
Interest expense |
| 19 | 19 | | 16 | 16 | ||||||||||||||||||
Interest income |
(1 | ) | | (1 | ) | (1 | ) | | (1 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total |
17 | 35 | 52 | 47 | 32 | 79 | ||||||||||||||||||
of which discontinued operations |
1 | (2 | ) | (1 | ) | 2 | | 2 | ||||||||||||||||
Retiree Medical |
||||||||||||||||||||||||
Interest expense |
| 3 | 3 | | 2 | 2 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total |
| 3 | 3 | | 2 | 2 | ||||||||||||||||||
Defined-contribution plans |
||||||||||||||||||||||||
Cost |
1 | 34 | 35 | 1 | 29 | 30 | ||||||||||||||||||
of which discontinued operations |
| 1 | 1 | | 1 | 1 |
Specification of pension costs
January to December |
||||||||||||||||||||||||
2012 |
2013 |
|||||||||||||||||||||||
Netherlands | other | total | Netherlands | other | total | |||||||||||||||||||
Defined-benefit plans |
||||||||||||||||||||||||
Pensions |
||||||||||||||||||||||||
Current service cost |
174 | 86 | 260 | 192 | 82 | 274 | ||||||||||||||||||
Past service cost (incl. curtailments) |
(25 | ) | (6 | ) | (31 | ) | | (81 | ) | (81 | ) | |||||||||||||
Settlements |
| 1 | 1 | | 32 | 32 | ||||||||||||||||||
Interest expense |
| 76 | 76 | | 65 | 65 | ||||||||||||||||||
Interest income |
(4 | ) | | (4 | ) | (4 | ) | | (4 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total |
145 | 157 | 302 | 188 | 98 | 286 | ||||||||||||||||||
of which discontinued operations |
2 | (1 | ) | 1 | 3 | | 3 | |||||||||||||||||
Retiree Medical |
||||||||||||||||||||||||
Current service cost |
| 1 | 1 | | 1 | 1 | ||||||||||||||||||
Past service cost (incl. curtailments) |
| (25 | ) | (25 | ) | | | | ||||||||||||||||
Interest expense |
| 12 | 12 | | 10 | 10 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total |
| (12 | ) | (12 | ) | | 11 | 11 | ||||||||||||||||
Defined-contribution plans |
||||||||||||||||||||||||
Cost |
9 | 135 | 144 | 8 | 134 | 142 | ||||||||||||||||||
of which discontinued operations |
1 | 4 | 5 | | 3 | 3 |
Q4 2013 Quarterly report 33
Reconciliation of non-GAAP performance measures
in millions of euros unless otherwise stated
Certain non-GAAP financial measures are presented when discussing the Philips Groups performance. In the following tables, a reconciliation to the most directly comparable IFRS performance measure is made.
Sales growth composition
in %
4th quarter |
January to December |
|||||||||||||||||||||||||||||||
comparable growth |
currency effects |
consolidation changes |
nominal growth |
comparable growth |
currency effects |
consolidation changes |
nominal growth |
|||||||||||||||||||||||||
2013 versus 2012 |
||||||||||||||||||||||||||||||||
Healthcare |
4.0 | (6.7 | ) | (0.4 | ) | (3.1 | ) | 0.8 | (4.6 | ) | (0.3 | ) | (4.1 | ) | ||||||||||||||||||
Consumer Lifestyle |
8.2 | (5.1 | ) | 0.0 | 3.1 | 10.0 | (3.4 | ) | 0.0 | 6.6 | ||||||||||||||||||||||
Lighting |
8.0 | (6.2 | ) | 0.1 | 1.9 | 3.2 | (3.5 | ) | 0.0 | (0.3 | ) | |||||||||||||||||||||
Innovation, Group & Services |
14.9 | (0.6 | ) | 7.9 | 22.2 | (2.0 | ) | (0.5 | ) | 5.7 | 3.2 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Philips Group |
6.5 | (6.0 | ) | 0.1 | 0.6 | 3.3 | (3.9 | ) | 0.1 | (0.5 | ) |
EBITA (or Adjusted income from operations) to Income from operations (or EBIT)
4th quarter | January to December |
|||||||||||||||||||||||||||||||
Income from operations (or EBIT) |
Amortization intangibles1) |
Impairment of goodwill |
EBITA (or Adjusted income from operations) |
Income from operations (or EBIT) |
Amortization intangibles1) |
Impairment of goodwill |
EBITA (or Adjusted income from operations) |
|||||||||||||||||||||||||
2013 |
||||||||||||||||||||||||||||||||
Healthcare |
477 | (62 | ) | (2 | ) | 541 | 1,315 | (195 | ) | (2 | ) | 1,512 | ||||||||||||||||||||
Consumer Lifestyle |
174 | (13 | ) | | 187 | 429 | (54 | ) | | 483 | ||||||||||||||||||||||
Lighting |
124 | (68 | ) | (26 | ) | 218 | 489 | (180 | ) | (26 | ) | 695 | ||||||||||||||||||||
Innovation, Group & Services |
(62 | ) | | | (62 | ) | (242 | ) | (3 | ) | | (239 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Philips Group |
713 | (143 | ) | (28 | ) | 884 | 1,991 | (432 | ) | (28 | ) | 2,451 | ||||||||||||||||||||
2012 |
||||||||||||||||||||||||||||||||
Healthcare |
361 | (50 | ) | | 411 | 1,026 | (200 | ) | | 1,226 | ||||||||||||||||||||||
Consumer Lifestyle |
113 | (14 | ) | | 127 | 400 | (56 | ) | | 456 | ||||||||||||||||||||||
Lighting |
(88 | ) | (60 | ) | | (28 | ) | (66 | ) | (194 | ) | | 128 | |||||||||||||||||||
Innovation, Group & Services |
(562 | ) | (2 | ) | | (560 | ) | (712 | ) | (8 | ) | | (704 | ) | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Philips Group |
(176 | ) | (126 | ) | | (50 | ) | 648 | (458 | ) | | 1,106 |
1) | Excluding amortization of software and product development |
34 Q4 2013 Quarterly report
Reconciliation of non-GAAP performance measures (continued)
in millions of euros
Net operating capital to total assets
Consumer | ||||||||||||||||||||
Philips Group | Healthcare | Lifestyle | Lighting | IG&S | ||||||||||||||||
December 31, 2013 |
||||||||||||||||||||
Net operating capital (NOC) |
10,238 | 7,437 | 1,261 | 4,462 | (2,922 | ) | ||||||||||||||
Exclude liabilities comprised in NOC: |
||||||||||||||||||||
- payables/liabilities |
8,453 | 2,541 | 1,275 | 1,672 | 2,965 | |||||||||||||||
- intercompany accounts |
| 124 | 75 | 105 | (304 | ) | ||||||||||||||
- provisions |
2,554 | 278 | 221 | 452 | 1,603 | |||||||||||||||
Include assets not comprised in NOC: |
||||||||||||||||||||
- investments in associates |
161 | 85 | | 20 | 56 | |||||||||||||||
- other current financial assets |
10 | | | | 10 | |||||||||||||||
- other non-current financial assets |
496 | | | | 496 | |||||||||||||||
- deferred tax assets |
1,675 | | | | 1,675 | |||||||||||||||
- cash and cash equivalents |
2,465 | | | | 2,465 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
26,052 | 10,465 | 2,832 | 6,711 | 6,044 | ||||||||||||||||
Assets classified as held for sale |
507 | |||||||||||||||||||
|
|
|||||||||||||||||||
Total assets |
26,559 | |||||||||||||||||||
December 31, 2012 |
||||||||||||||||||||
Net operating capital (NOC) |
9,316 | 7,976 | 1,205 | 4,635 | (4,500 | ) | ||||||||||||||
Exclude liabilities comprised in NOC: |
||||||||||||||||||||
- payables/liabilities |
10,287 | 2,760 | 1,718 | 1,695 | 4,114 | |||||||||||||||
- intercompany accounts |
| 71 | 42 | 37 | (150 | ) | ||||||||||||||
- provisions |
2,956 | 355 | 315 | 581 | 1,705 | |||||||||||||||
Include assets not comprised in NOC: |
||||||||||||||||||||
- investments in associates |
177 | 86 | | 22 | 69 | |||||||||||||||
- other non-current financial assets |
549 | | | | 549 | |||||||||||||||
- deferred tax assets |
1,919 | | | | 1,919 | |||||||||||||||
- cash and cash equivalents |
3,834 | | | | 3,834 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
29,038 | 11,248 | 3,280 | 6,970 | 7,540 | ||||||||||||||||
Assets classified as held for sale |
43 | |||||||||||||||||||
|
|
|||||||||||||||||||
Total assets |
29,081 |
Q4 2013 Quarterly report 35
Reconciliation of non-GAAP performance measures (continued)
in millions of euros
Composition of net debt to group equity
December 31, 2012 |
December 31, 2013 |
|||||||
Long-term debt |
3,725 | 3,309 | ||||||
Short-term debt |
809 | 592 | ||||||
|
|
|
|
|||||
Total debt |
4,534 | 3,901 | ||||||
Cash and cash equivalents |
3,834 | 2,465 | ||||||
|
|
|
|
|||||
Net debt (total debt less cash and cash equivalents) |
700 | 1,436 | ||||||
Shareholders equity |
11,151 | 11,214 | ||||||
Non-controlling interests |
34 | 13 | ||||||
|
|
|
|
|||||
Group equity |
11,185 | 11,227 | ||||||
Net debt and group equity |
11,885 | 12,663 | ||||||
Net debt divided by net debt and group equity (in %) |
6 | 11 | ||||||
Group equity divided by net debt and group equity (in %) |
94 | 89 |
Composition of cash flows
4th quarter | January to December | |||||||||||||||
2012 | 2013 | 2012 | 2013 | |||||||||||||
Cash flows provided by operating activities |
1,056 | 905 | 2,082 | 1,138 | ||||||||||||
Cash flows used for investing activities |
(316 | ) | (325 | ) | (925 | ) | (997 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Cash flows before financing activities |
740 | 580 | 1,157 | 141 | ||||||||||||
Cash flows provided by operating activities |
1,056 | 905 | 2,082 | 1,138 | ||||||||||||
Net capital expenditures: |
(303 | ) | (297 | ) | (455 | ) | (966 | ) | ||||||||
Purchase of intangible assets |
(9 | ) | (32 | ) | (34 | ) | (49 | ) | ||||||||
Proceeds from sale of intangible assets |
| | 160 | | ||||||||||||
Expenditures on development assets |
(95 | ) | (89 | ) | (345 | ) | (357 | ) | ||||||||
Capital expenditures on property, plant and equipment |
(212 | ) | (181 | ) | (661 | ) | (587 | ) | ||||||||
Proceeds from sale of property, plant and equipment |
13 | 5 | 425 | 27 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Free cash flows |
753 | 608 | 1,627 | 172 |
36 Q4 2013 Quarterly report
© 2014 Koninklijke Philips N.V. | http://www.philips.com/investorrelations | |
All rights reserved. |